| Latvia | | |
Time spent for sleeping (men and women, minutes per day per person) | 512.3 (2003) [12/30countries] | | | Time spent for sleeping (men, minutes per day per person) | 510.1 (2003) [10/30countries] | | | Time spent for sleeping (women, minutes per day per person) | 515.5 (2003) [9/30countries] | | |
|
| Latvia | | |
Time spent for eating and drinking (men and women, minutes per day per person) | 88.9 (2003) [17/30countries] | | | Time spent for eating and drinking (men, minutes per day per person) | 93.0 (2003) [14/30countries] | | | Time spent for eating and drinking (women, minutes per day per person) | 84.9 (2003) [19/30countries] | | |
|
| Latvia | | |
Age-standardized prevalence of tobacco use among persons 15 years and olders (%) | 37.0% (2020) [1/38countries] | | |
|
| Latvia | | |
Tuberculosis incidence (per 100,000 population) | 16.0 (2021) [6/38countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.3 (2020) [8/38countries] | | | Reported number of people requiring interventions against NTDs | 6 (2021) [13/34countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 21.6 (2019) [2/38countries] | | | % of those who think that antibiotics can kill bacteria but not viruses | 68.0% (2000) [22/22countries] | | | % of those who think that all man-made chemicals can cause cancer if they eat enough of them | 71.2% (2000) [10/22countries] | | |
|
| Latvia | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 301.5 (2020) [16/38countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 12.3 (2020) [13/38countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 7.5 (2020) [2/38countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 63.6 (2020) [30/38countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 18.4 (2020) [3/38countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 92.5 (2020) [7/38countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 17.6 (2020) [11/38countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.4 (2020) [31/38countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 13.5 (2020) [4/38countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 3.4 (2020) [6/38countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 7.8 (2020) [19/38countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 6.0 (2020) [4/38countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 3.2 (2020) [36/38countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 26.4 (2020) [23/38countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 11.7 (2020) [30/38countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 2.6 (2020) [29/38countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [21/37countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 9.8 (2020) [29/38countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 3.7 (2020) [11/38countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 1.5 (2020) [23/38countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 15.1 (2020) [1/38countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 8.8 (2020) [7/38countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 87.6 (2020) [8/38countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 12.0 (2020) [9/38countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 3.1 (2020) [36/38countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 10.2 (2020) [13/38countries] | | |
|
| Latvia | | |
Suicide, age-standardized (per 100 000 population) | 16.06 (2019) [3/38countries] | | | Suicide - male, age-standardized (per 100 000 population) | 29.01 (2019) [3/38countries] | | | Suicide - female, age-standardized (per 100 000 population) | 4.56 (2019) [18/38countries] | | | Suicide - 15-24 years (per 100,000 population) | 10.01 (2019) [13/38countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 17.84 (2019) [7/38countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 1.74 (2019) [32/38countries] | | | Suicide - 25-34 years (per 100,000 population) | 22.22 (2019) [4/38countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 36.57 (2019) [3/38countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 7.10 (2019) [7/38countries] | | | Suicide - 35-44 years (per 100,000 population) | 24.46 (2019) [3/38countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 43.01 (2019) [2/38countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 5.94 (2019) [18/38countries] | | | Suicide - 45-54 years (per 100,000 population) | 28.85 (2019) [3/38countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 53.52 (2019) [2/38countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 6.15 (2019) [27/38countries] | | | Suicide - 55-64 years (per 100,000 population) | 26.71 (2019) [5/38countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 51.20 (2019) [3/38countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 7.03 (2019) [22/38countries] | | | Suicide - 65-74 years (per 100,000 population) | 21.48 (2019) [7/38countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 42.95 (2019) [5/38countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 8.35 (2019) [17/38countries] | | | Suicide - 75-84 years (per 100,000 population) | 26.93 (2019) [9/38countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 57.96 (2019) [6/38countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 13.16 (2019) [12/38countries] | | | Suicide - 85 years and over (per 100,000 population) | 25.59 (2019) [14/38countries] | | |
|
| Latvia | | |
Density of medical doctors (per 10,000 population) | 33.5 (2013?2021) [25/38countries] | | | Density of nursing and midwifery personnel (per 10,000 population) | 44.0 (2013?2021) [33/38countries] | | | Density of dentists (per 10,000 population) | 7.2 (2013?2021) [22/38countries] | | | Density of pharmacists (per 10,000 population) | 8.8 (2013?2021) [19/37countries] | | | Hospital beds (number per 1,000 population) | 5.5 (2018) [12/38countries] | | | Inpatient care average length of stay days | 7.8 (2022) [13/34countries] | | | Health expenditure (% of GDP) | 8.8% (2022) [22/38countries] | | | Population with household expenditures on health > 10% of total household expenditure or income (%) | 21.4 (2013?2021) [1/23countries] | | | % of those who agree that the government is responsible for providing health care for the sick | 98.1% (2016) [7/25countries] | | | % of those who would like to see more government spending in health | 90.7% (2016) [4/25countries] | | | % of those who think that the government is successful in health care | 10.2% (2016) [15/15countries] | | | % of those who think that hospitals should mainly be run by private organizations or companies | 14.6% (1996) [14/18countries] | | |
|
|